Recludix
San Diego, US · 54 employees on LinkedIn · 3 known investors
Recludix Pharma operates a drug discovery platform that combines custom DNA-encoded libraries (DELs), massively parallel structure-activity relationship analysis, structure-based design, and a family-wide SH2 domain screening panel. It applies this approach first to discover selective SH2 domain inhibitors for treating inflammatory diseases.
Founders & leadership
NW
Nancy WhitinginCEO
Investors · 3
Frequently asked questions
- What does Recludix do?
- Recludix Pharma operates a drug discovery platform that combines custom DNA-encoded libraries (DELs), massively parallel structure-activity relationship analysis, structure-based design, and a family-wide SH2 domain screening panel. It applies this approach first to discover selective SH2 domain inhibitors for treating inflammatory diseases.
- Who are Recludix's investors?
- Recludix's investors include Access Biotechnology, New Enterprise Associates (NEA), Westlake Village BioPartners.
- Where is Recludix headquartered?
- Recludix is headquartered in San Diego, US.